High incidence of venous thromboembolism in patients with lymphoma receiving chemotherapy: Assessment of risk factors.

被引:0
|
作者
Teegala, Shyam [1 ]
Zhou, Xiao [1 ]
Huen, Auris [1 ]
Fayad, Luis [1 ]
Romaguera, Jorge Enrique [1 ]
Hagemeister, F. B. [1 ]
Vadhan-Raj, Saroj [1 ]
机构
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4103
引用
收藏
页码:105B / 106B
页数:2
相关论文
共 50 条
  • [1] Comparison of venous thromboembolism risk assessment models in patients receiving chemotherapy
    Talasiewicz, K.
    Ozdowska, P.
    Milanowska, B.
    Gepner, K.
    Jagielska, B.
    ANNALS OF ONCOLOGY, 2018, 29
  • [2] Incidence and risk factors for venous thromboembolism in cancer patients qualifying for chemotherapy
    van Sluis, G. L.
    Verberne, L.
    Kok, M.
    van Houwelingen, J. C.
    Buller, H. R.
    Otten, H. -M. M. B.
    THROMBOSIS RESEARCH, 2010, 125 : S166 - S166
  • [3] Incidence and Risk of Venous Thromboembolism in Patients With Resectable Pancreatic Cancer Receiving Neoadjuvant Chemotherapy
    Kamiya, Mariko
    Kawahara, Shinnosuke
    Kamioka, Yuto
    Murakawa, Masaaki
    Aoyama, Toru
    Kobayashi, Satoshi
    Ueno, Makoto
    Yamamoto, Naoto
    Oshima, Takashi
    Yukawa, Norio
    Rino, Yasushi
    Masuda, Munetaka
    Morinaga, Soichiro
    ANTICANCER RESEARCH, 2023, 43 (04) : 1741 - 1747
  • [4] Incidence, Risk Factors, and Modified Risk Assessment Model of Venous Thromboembolism in Non-Hodgkin Lymphoma Patients
    Li, Wen
    Liu, Rui
    Shen, Ying
    Gao, Gongzhizi
    Yang, Rui
    Wang, Yiwen
    Yang, Ruoyu
    Lin, Zujie
    Dong, Ruijun
    Zhao, Wanhong
    He, Aili
    Bai, Ju
    CANCER MEDICINE, 2024, 13 (24):
  • [5] Incidence, risk factors and management of venous thromboembolism in patients with primary CNS lymphoma
    Saito, Miyabi
    Wages, Nolan A.
    Schiff, David
    JOURNAL OF NEURO-ONCOLOGY, 2021, 154 (01) : 41 - 47
  • [6] Incidence, risk factors and management of venous thromboembolism in patients with primary CNS lymphoma
    Miyabi Saito
    Nolan A. Wages
    David Schiff
    Journal of Neuro-Oncology, 2021, 154 : 41 - 47
  • [7] Incidence and Risk Factors of Venous Thromboembolism in Patients with Multiple Myeloma Receiving Immunomodulatory Agents
    Kimpton, Miriam
    Buyting, Ryan
    Corsi, Daniel J.
    Rupani, Natasha
    Carrier, Marc
    McCurdy, Arleigh
    BLOOD, 2016, 128 (22)
  • [8] Higher incidence of venous thromboembolism is associated with initial cycles of chemotherapy in lymphoma patients: Creatinine and hemoglobin as key risk factors
    Zhou, Xiao
    Huen, Auris
    Teegala, Shyana
    Ji, Yuan
    Fayad, Luis
    Hagemeister, F. B.
    Vadhan-Raj, Saroj
    BLOOD, 2007, 110 (11) : 66B - 66B
  • [9] Incidence and risk factors for severe thrombocytopenia in lymphoma patients receiving chemotherapy.
    Zhou, Xiao
    Teegala, Shyam
    Ji, Yuan
    Fayad, Luis
    Romaguera, Jorge Enrique
    Hagemeister, F. B.
    Vadhan-Raj, Saroj
    BLOOD, 2006, 108 (11) : 76B - 76B
  • [10] Correction to: Incidence, risk factors and management of venous thromboembolism in patients with primary CNS lymphoma
    Miyabi Saito
    Nolan A. Wages
    David Schiff
    Journal of Neuro-Oncology, 2021, 154 : 49 - 49